Atlas Trials

Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)

Clinical trial NCT01318200 · WITHDRAWN

Trial details

NCT number
NCT01318200
Sponsor
Accuray Incorporated
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent Hepatocellular Carcinoma
Start date
2011-02-01
Primary completion
2014-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.